Rapid improvements in MADRS with zuranolone in major depressive disorder and postpartum depression: results from the LANDSCAPE/NEST clinical development programmes

MLA

A. H. Clayton, et al. “Rapid Improvements in MADRS with Zuranolone in Major Depressive Disorder and Postpartum Depression: Results from the LANDSCAPE/NEST Clinical Development Programmes.” European Psychiatry, vol. 66, Mar. 2023, pp. S93–94. EBSCOhost, https://doi.org/10.1192/j.eurpsy.2023.276.

APA

A. H. Clayton, K. M. Deligiannidis, J. A. Ramos-Quiroga, R. Lasser, A. J. Sankoh, B. Leclair, M. Kotecha, & J. Doherty. (2023). Rapid improvements in MADRS with zuranolone in major depressive disorder and postpartum depression: results from the LANDSCAPE/NEST clinical development programmes. European Psychiatry, 66, S93–S94. https://doi.org/10.1192/j.eurpsy.2023.276

Chicago

A. H. Clayton, K. M. Deligiannidis, J. A. Ramos-Quiroga, R. Lasser, A. J. Sankoh, B. Leclair, M. Kotecha, and J. Doherty. 2023. “Rapid Improvements in MADRS with Zuranolone in Major Depressive Disorder and Postpartum Depression: Results from the LANDSCAPE/NEST Clinical Development Programmes.” European Psychiatry 66 (March): S93–94. doi:10.1192/j.eurpsy.2023.276.